COMPOSÉ IRIDINESULFONAMIDE ET SON PROCÉDÉ D'UTILISATION

• 收藏
• 分享

专利权人:

Chai Tai Tianqing Pharmaceutical Group Co., Ltd.;Lianyungang Runzhong Pharmaceutical Co., Ltd.;Centaurus BioPharma Co., Ltd.

发明人:

ZHU, Li,YANG, Yanqing,DAI, Liguang,DUAN, Xiaowei,YANG, Zhao,ZHANG, Hui,HU, Yuandong,PENG, Yong,HAN, Yongxin,ZHAO, Rui,TIAN, Xin,WANG, Shanchun

申请号：

EP17769433

公开号：

EP3444237A4

申请日:

2017.03.22

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

An iridinesulfonamide compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity, pharmaceutically acceptable salts, solvates or hydrates thereof, a pharmaceutical composition, as well as use of the compound or the pharmaceutically acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition thereof in treating IDH1 mutation- induced cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/